Trials / Recruiting
RecruitingNCT02748408
The Medacta International SMS Post-Marketing Surveillance Study
The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 550 (estimated)
- Sponsor
- Medacta International SA · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.
Conditions
- Arthrosis
- Traumatic Arthritis
- Rheumatoid Polyarthritis
- Congenital Hip Dysplasia
- Avascular Necrosis of the Femoral Head
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SMS femoral stem |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2032-07-01
- Completion
- 2032-07-01
- First posted
- 2016-04-22
- Last updated
- 2025-09-29
Locations
4 sites across 4 countries: Austria, Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02748408. Inclusion in this directory is not an endorsement.